Huntsman Cancer Institute researchers identify promising drug combination for melanoma
Source: EurekAlert!, December 2020
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) have identified a potential drug combination to treat uveal melanoma, a type of eye cancer.
Lead author Amanda Truong, trainee in the McMahon Lab at HCI and student at the U of U, explains uveal melanoma patients frequently have changes in genes called GNAQ and GNA11, which are key targets for these drugs.
This study was published in the journal Clinical Cancer Research.